Columbus, Ohio-based Deep Lens, an AI-driven digital pathology company focused on clinical trial recruitment at the time of diagnosis, has closed a $14 million Series A financing round.
The investment was led by Northpond Ventures. Existing investors Rev1 Ventures, Sierra Ventures, and Tamarind-Hill Partners also participated in this round.
The funding comes three months after Deep Lens closed its VC-led seed equity round. Deep Lens has a total of $17.5 million to date.
[Image courtesy: Deep Lens]